ALB and chronic kidney disease: Increased urinary albumin and FFA exposure may increase 1-deoxysphingolipid levels in proximal tubules in CKD patients and 5/6 Nx-treated animal models of CKD and can lead to tubular damage, oxidative stress, and mitochondrial dysfunction (Gui et al., 2021).